Cash Flow Statement
Growth Metrics

Sintx Technologies (SINT) Shares Repurchased (2015 - 2025)

Sintx Technologies' quarterly Shares Repurchased came in at $47000.0 in Q2 2025, down 45.35% quarter-over-quarter from $86000.0 in Q1 2025.

Sintx Technologies has reported Shares Repurchased for 2 years, with the latest figure at $47000.0 in Q2 2025.

  • For the quarter ending Q2 2025, Shares Repurchased changed N/A year-over-year to $47000.0; the trailing twelve-month figure through Dec 2025 stood at $133000.0 (changed N/A YoY), and the FY2025 full-year result was $133000.0, changed N/A from the prior year.
  • Shares Repurchased for Q2 2025 stood at $47000.0, down from $86000.0 in the prior quarter.
  • The five-year high for Shares Repurchased was $86000.0 in Q1 2025, with the low at $47000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 180.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 105.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 421.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 100.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 74.30 Mn
10 Sintx Technologies 8.71 Mn 6.82 Mn 144,000.00 -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 47,000.00
Jun 30, 2025 47,000.00
Mar 31, 2025 86,000.00
Mar 31, 2025 86,000.00
Mar 31, 2015 120,000.00
Mar 31, 2015 120,000.00